Power 3 Medical’s Stock Watch brought to you by Stock-PR.com
Stock-PR Reporting
FREE Daily Stock Alerts From Stock-PR.com
________________________________________
Power 3 Medical’s - (OTC BB: PWRM.OB) research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications:
* Breast Cancer
* Chemotherapeutic Drug Resistance
* Alzheimer’s Disease
* Leukemia
* ALS (Lou Gehrig’s Disease)
* Gastrointestinal Disease
* Parkinson’s Disease
* Metabolic Syndrome
Recently announced PWRM has new research and unexpectedly discovered new and unprecedented findings regarding clinically important differences in the response of the NuroPro® protein biomarkers in the blood. These results relate to the genetically distinct groups of Alzheimer’s disease patients, i.e., those individuals who possess the Alzheimer’s high-risk gene for Apolipoprotein E4 and those who do not possess the gene.
NuroPro® was originally indicated for diagnostics to determine whether or not a patient had Alzheimer’s disease. With these new results, NuroPro® now extends into the pharmaceutical arena due to its ability to predict and monitor the response to drug treatment, including the underlying disease process and the insidious progression of irreversible neurological damage, even in the face of temporary improvements in cognition and other symptoms.
Power3 has filed for 2 patent protections, one on Alzheimer’s disease specific differential diagnosis in the clinical setting and the other on important differences in pathophysiology and therapeutic options for the genetically distinct groups of Alzheimer’s disease patients.
Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
________________________________________
Be Sure To Visit stock-pr.ning.com
********************************
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings, Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.
